Absorption of topical tacrolimus (FK506) in vitro through human skin: Comparison with cyclosporin A

Skin Pharmacology and Physiology

Volumn 10, Issue 5-6, 1997, Pages 230-234

  Lauerma, Antti I ^a,b   Surber, Christian ^c   Maibach, Howard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cyclosporin A; Skin absorption; Tacrolimus

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYRISTIC ACID ISOPROPYL ESTER; OCTANOL; TACROLIMUS; WATER;

ADULT; ARTICLE; CADAVER; CASE REPORT; CONTROLLED STUDY; DERMATOME; DRUG ABSORPTION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN DISEASE; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; SKIN ABSORPTION; TACROLIMUS;

EID: 0031464929     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000211510     Document Type: Article

References (19)

1. Müller W, Hermann B: Cyclosporin A for psoriasis. N Engl J Med 1979; 301:555.
2. Lauerma AI, Granlund H, Reitamo S: Use of the newer immunosuppressive agents in dermatology. Biodrugs 1997;8:96-106.
3. Hermann RC, Taylor RS, Ellis CN, Williams N, Weiner ND, Flynn GL, Annesley TM, Voorhees JJ: Topical ciclosporin for psoriasis: In vitro skin penetration and clinical study. Skin Pharmacol 1988;1:246-249.
4. Reitamo S, Käyhkö K, Laucrma AI, Mustakallio KK: Topical cyclospo-rine and contact dermatitis in guinea pig and man. Arch Dermatol 1989; 125:568.
5. Surber C, Itin P, Büchner S, Mai-bach HI: Effect of a new topical cyclosporin formulation on human allergic contact dermatitis. Contact Dermatitis 1992;26:116-119.
6. Eisen D, Ellis CN, Duell EA, Griffiths CE, Voorhees JJ: Effect of topical cyclosporine rinse on oral lichen planus: A double-blind analysis. N Engl J Med 1990;323:290-294.
7. Migozuchi M, Kawaguchi K, Ohsuga Y, Ikary Y, Yanagawa A, Mizu-shima Y: Cyclosporin ointment for psoriasis and atopic dermatitis. Lancet 1992;339:1120.
8. Surber C, Itin P, Büchner S: Clinical controversy on the effect of topical ciclosporin: What is the target site? Dermatology 1992;185:242-245.
9. Burns MK, Ellis CN, Eisen D, Duell E, Griffiths CE, Annesley TM, Hamilton TA, Birnbaum JE, Voorhees JJ: Intralesional cyclosporine for psoriasis: Relationship of dose, tissue levels, and efficacy. Arch Dermatol 1992;128:786-790.
10. Schreiber SL, Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-142.
11. Abu-Elmagd K, Van Thiel D, Jega-sothy BV, Ackerman CD, Todo S, Fung JJ, Thomson AW, Starzl TE: FK506: A new therapeutic agent for severe recalcitrant psoriasis. Transplant Proc 1991;23:3322-3324.
12. Lauerma AI, Maibach HI, Granlund H, Erkko P, Kartamaa M, Stubb S: Inhibition of contact allergy reactions by topical FK506. Lancet 1992;340:556.
13. Nakagawa H, Etoh T, Ishibashi Y, Higaki Y, Kawashima M, Torii H, Harada S: Tacrolimus ointment for atopic dermatitis. Lancet 1994:344: 883.
14. Lauerma AI, Maibach HI: Topical FK506 - Clinical potential or laboratory curiosity? Dermatology 1994; 188:173-176.
15. Surber C, Wilhelm K-P, Hori M, Maibach HI, Guy RH: Optimization of topical therapy: Partitioning of drugs into stratum comeum. Pharm Res 1990;7:1320-1324.
16. Dun WJ III, Block JH, Pearlman RS: Partition Coefficient Determination and Estimation. New York, Pcrgamon Press, 1986.
17. Skelly JP, Shah VP, Maibach HI, Guy RH, Wester RC, Flynn G. Ya-cobi A: FDA and AAPS report on principles and practices of in vitro percutaneous penetration studies: Relevance to bioavailability and biocquivalcncc. Pharm Res 1987;4: 265-267.
18. Bucks DAW, McMaster JMA, Maibach HI, Guy RH: Bioavailability of topically administered steroids: A ‘mass’ balance technique. J Invest Dermatol 1988;91:29-33.
19. Surber C, Wilhelm K-P, Maibach HI: In-vitro skin pharmacokinetics of acitretin: Percutaneous absorption studies in intact and modified skin from three different species using different receptor solutions. J Pharm Pharmacol 1991;43:836-840.